Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
2011

BMI-1 and Its Role in Osteosarcoma Growth and Chemotherapy Resistance

Sample size: 90 publication Evidence: moderate

Author Information

Author(s): Wu Zhihong, Min Li, Chen Dafu, Hao Dongsheng, Duan Yuanhui, Qiu Guixing, Wang Yipeng

Primary Institution: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Hypothesis

Does BMI-1 function as an oncogene in osteosarcoma?

Conclusion

The study found that BMI-1 promotes tumor growth and resistance to cisplatin in osteosarcoma cells.

Supporting Evidence

  • BMI-1 was overexpressed in various osteosarcoma samples.
  • Knockdown of BMI-1 reduced cell viability and tumor growth.
  • BMI-1 depletion increased sensitivity to cisplatin-induced apoptosis.

Takeaway

BMI-1 is a protein that helps cancer cells grow, and when we reduce it, the cancer cells can die more easily when treated with a drug called cisplatin.

Methodology

The study used RNA interference to knock down BMI-1 in osteosarcoma cells and assessed its effects on cell growth, migration, and response to cisplatin.

Limitations

The study primarily focused on a single type of cancer and may not be generalizable to all cancers.

Participant Demographics

Patients histologically confirmed with osteosarcoma, chondrosarcoma, Ewing sarcoma, osteochondroma, and normal bone tissues.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0014648

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication